The store will not work correctly when cookies are disabled.
4-[6-Amino-5-(4-cyanophenyl)pyridin-3-yl]benzoic acid
ID: ALA4753817
PubChem CID: 162653462
Max Phase: Preclinical
Molecular Formula: C19H13N3O2
Molecular Weight: 315.33
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1ccc(-c2cc(-c3ccc(C(=O)O)cc3)cnc2N)cc1
Standard InChI: InChI=1S/C19H13N3O2/c20-10-12-1-3-14(4-2-12)17-9-16(11-22-18(17)21)13-5-7-15(8-6-13)19(23)24/h1-9,11H,(H2,21,22)(H,23,24)
Standard InChI Key: QTQGRBFWPPBCSH-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
6.4164 -9.6081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4153 -10.4277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1233 -10.8367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8330 -10.4272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8302 -9.6046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1215 -9.1993 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5378 -10.8339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5378 -11.6522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2453 -12.0596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9533 -11.6499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9494 -10.8285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2413 -10.4248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5363 -9.1933 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7091 -10.8360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0015 -10.4251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2939 -10.8325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2928 -11.6506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0052 -12.0596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7098 -11.6498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5823 -12.0611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8744 -11.6529 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5827 -12.8783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6611 -12.0548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3700 -12.4613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
4 7 1 0
5 13 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
2 14 1 0
20 21 1 0
20 22 2 0
17 20 1 0
23 24 3 0
10 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 315.33 | Molecular Weight (Monoisotopic): 315.1008 | AlogP: 3.57 | #Rotatable Bonds: 3 |
Polar Surface Area: 100.00 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.02 | CX Basic pKa: 7.01 | CX LogP: 1.63 | CX LogD: 1.11 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.77 | Np Likeness Score: -0.64 |
References
1. Dow RL,Ammirati M,Bagley SW,Bhattacharya SK,Buckbinder L,Cortes C,El-Kattan AF,Ford K,Freeman GB,Guimarães CRW,Liu S,Niosi M,Skoura A,Tess D. (2018) 2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety., 61 (7): [PMID:29570292] [10.1021/acs.jmedchem.8b00152] |